Literature DB >> 21334755

Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005.

Tiew-Hwa Katherine Teng1, Joseph Hung, Matthew Knuiman, Simon Stewart, Leonard Arnolda, Ian Jacobs, Michael Hobbs, Frank Sanfilippo, Elizabeth Geelhoed, Judith Finn.   

Abstract

BACKGROUND: It is uncertain if improvements in long-term cardiovascular (CV) mortality have occurred in both men and women with ischemic and non-ischemic forms of heart failure (HF).
METHODS: The Western Australia Hospital Morbidity Database was used to identify all index (first-ever) hospitalizations for HF between 1990 and 2005. Patients were followed until death attributed to cardiovascular causes or censored on December 31, 2006 to determine 5-year survival. Cox proportional hazards models were used to compare the adjusted mortality hazard ratio (HR) during the study follow-up (4-year periods).
RESULTS: A total of 21,507 patients (mean age 73.9 years, 49.1% women) were identified. Women were significantly older than men, and less likely to have ischemic HF (38.8% versus 46.1%). Over the period, age-standardized incidence of first HF hospitalization declined but with the least decline in women with non-ischemic HF (-13.3%) compared to other subgroups. Risk-adjusted 5-year CV mortality declined over the study period, with HR 0.64 (95% CI 0.60-0.68) for patients admitted in 1998-2001 compared to 1990-1993, with significant improvement in both forms of HF, and in both sexes and across age groups. However, overall total HF hospitalizations increased (+26.7%) over the period, particularly for non-ischemic HF (+43.7%), of which elderly women formed the predominant group.
CONCLUSIONS: Risk-adjusted long-term survival improved similarly in men and women, including the elderly, with ischemic and non-ischemic forms of HF during 1990-2005 in Western Australia. However, there was a growing burden of HF hospitalizations particularly for HF of non-ischemic aetiology.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21334755     DOI: 10.1016/j.ijcard.2011.01.061

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007.

Authors:  Darwin F Yeung; Nicole K Boom; Helen Guo; Douglas S Lee; Susan E Schultz; Jack V Tu
Journal:  CMAJ       Date:  2012-08-20       Impact factor: 8.262

Review 2.  The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.

Authors:  Ken Lee Chin; Marina Skiba; Andrew Tonkin; Christopher M Reid; Danny Liew; Henry Krum; Ingrid Hopper
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

3.  Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT.

Authors:  Yitschak Biton; Valentina Kutyifa; Wojciech Zareba; Helmut U Klein; Scott D Solomon; Scott McNitt; Bronislava Polonsky; Arthur J Moss; Ilan Goldenberg
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

4.  Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study.

Authors:  Kumar Dharmarajan; Angela F Hsieh; Vivek T Kulkarni; Zhenqiu Lin; Joseph S Ross; Leora I Horwitz; Nancy Kim; Lisa G Suter; Haiqun Lin; Sharon-Lise T Normand; Harlan M Krumholz
Journal:  BMJ       Date:  2015-02-05

5.  The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective.

Authors:  A Griffiths; N Paracha; A Davies; N Branscombe; M R Cowie; M Sculpher
Journal:  Heart       Date:  2014-03-14       Impact factor: 5.994

6.  A cohort study: temporal trends in prevalence of antecedents, comorbidities and mortality in Aboriginal and non-Aboriginal Australians with first heart failure hospitalization, 2000-2009.

Authors:  Tiew-Hwa Katherine Teng; Judith M Katzenellenbogen; Joseph Hung; Matthew Knuiman; Frank M Sanfilippo; Elizabeth Geelhoed; Dawn Bessarab; Michael Hobbs; Sandra C Thompson
Journal:  Int J Equity Health       Date:  2015-08-12

Review 7.  Chronic heart failure: we are fighting the battle, but are we winning the war?

Authors:  John J Atherton
Journal:  Scientifica (Cairo)       Date:  2012-12-20

8.  Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia.

Authors:  Joseph Hung; Tiew-Hwa Katherine Teng; Judith Finn; Matthew Knuiman; Thomas Briffa; Simon Stewart; Frank M Sanfilippo; Steven Ridout; Michael Hobbs
Journal:  J Am Heart Assoc       Date:  2013-10-08       Impact factor: 5.501

9.  Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors.

Authors:  Mateusz Mościński; Bożena Szyguła-Jurkiewicz; Michał Zakliczyński; Piotr Rozentryt; Robert Partyka; Marian Zembala; Lech Poloński
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-03-27

Review 10.  Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines.

Authors:  Pupalan Iyngkaran; Nadarajan Kangaharan; Hendrik Zimmet; Margaret Arstall; Rob Minson; Merlin C Thomas; Peter Bergin; John Atherton; Peter MacDonald; David L Hare; John D Horowitz; Marcus Ilton
Journal:  Curr Cardiol Rev       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.